MacroGenics (MGNX) awards stock options and RSUs to director Koenig

Rhea-AI Filing Summary

MacroGenics Inc. director Scott Koenig received new equity awards. He was granted stock options for 22,000 shares of common stock with an exercise price of $4.52 per share, expiring in 2036.

Koenig was also granted 3,750 restricted stock units, each representing one share of common stock. The RSUs vest one year after the grant date, or the day before the next annual meeting if earlier. The options vest in monthly 1/12th increments starting one month after grant.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Koenig Scott

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	3,750	$0.00	--
Grant/Award	Stock Option (right to buy)	22,000	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 3,750 shares (Direct, null); Stock Option (right to buy) — 22,000 shares (Direct, null)

Footnotes (1)

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Key Figures

Stock options granted: 22,000 shares Option exercise price: $4.52 per share Option expiration: 2036-05-19 +3 more

6 metrics

Stock options granted 22,000 shares Director grant of options to buy common stock

Option exercise price $4.52 per share Exercise price for 22,000 stock options

Option expiration 2036-05-19 Expiration date of newly granted options

RSUs granted 3,750 units Restricted stock units tied to one common share each

RSU vesting period 1 year Vest one year after grant or day before next annual meeting

Option vesting pace 1/12 monthly Options vest in monthly cumulative 1/12th increments

Key Terms

Stock Option (right to buy), Restricted Stock Unit, contingent right, vest, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

Restricted Stock Unit financial

"security_title: Restricted Stock Unit"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

contingent right financial

"represents a contingent right to receive one share"

vest financial

"The RSUs will vest one year after the date of grant"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

exercise price financial

"conversion_or_exercise_price: 4.5200"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koenig Scott

(Last) (First) (Middle)

9704 MEDICAL CENTER DRIVE

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MACROGENICS INC [ MGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0(1)	05/19/2026		A		3,750		(2)	(2)	Common Stock	3,750	$0	3,750	D
Stock Option (right to buy)	$4.52	05/19/2026		A		22,000		(3)	05/19/2036	Common Stock	22,000	$0	22,000	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

2. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

3. The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

Remarks:

	/s/ Beth A. Smith, Attorney-in-fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Scott Koenig receive in MacroGenics (MGNX) Form 4?

Scott Koenig received stock options for 22,000 shares and 3,750 restricted stock units. The options give him the right to buy MacroGenics common stock, while the RSUs represent future share delivery if vesting conditions are met.

What is the exercise price and expiration for Scott Koenig’s new MacroGenics options?

The newly granted stock options have an exercise price of $4.52 per share and expire in 2036. Koenig can exercise these options after they vest, potentially buying MacroGenics common stock at that fixed price if market conditions make it attractive.

How and when do Scott Koenig’s MacroGenics RSUs vest?

The 3,750 restricted stock units vest one year after the grant date, or the day before the next annual meeting, whichever comes first. Once vested, each RSU converts into one share of MacroGenics common stock, adding to Koenig’s direct equity stake.

What is the vesting schedule for Scott Koenig’s new MacroGenics stock options?

The stock options vest in monthly, cumulative 1/12th increments beginning one month after the grant date. This means the full 22,000-share option grant becomes exercisable over approximately one year, aligning director compensation with ongoing board service at MacroGenics.

Do Scott Koenig’s MacroGenics RSUs deliver cash or stock when vested?

The RSUs represent a contingent right to receive shares of MacroGenics common stock, not cash. Upon vesting, each of the 3,750 RSUs converts into one share, increasing Koenig’s ownership in the company if he remains eligible through the vesting date.